CD138, also known as Syndecan-1, is a type I transmembrane proteoglycan cell adhesion molecule overexpressed on transformed plasma cells that promotes angiogenesis, tumor growth and metastases, and adhesion to the TME [92,93], making it a viable target. This evidence concerns the gene SDC1 and neoplasm.